Okt. 28, 2022 | Corporate Finance, M&A
Deriving the adequate values per preferred and common share is not straightforward. Dividing the total equity value or agreed company pre-money valuation in a financing transaction by the total amount of existing shares to receive the issue price is not correct if...
Sep. 26, 2022 | Uncategorized
We are very pleased and happy to have celebrated the opening of our new office space and our refreshed branding with you, our clients and partners.
Aug. 29, 2022 | Corporate Finance, M&A
Start-ups in the Life Sciences field are frequently financed through a combination of equity securities with different rights to its holders. There are several economic rationales behind preferred rights for large investors. Whereas certain (e.g. non-participating)...
Aug. 29, 2022 | Corporate Finance, M&A
In our last M&A newsletter (The meaning of preferential rights embedded in preferred shares and empirical evidence in Switzerland) we introduced the nature and economic meaning of different preferential rights embedded in preferred shares.In addition, we have...
